Patents by Inventor Stella A. Martomo

Stella A. Martomo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOMODULATORY AGENTS
    Publication number: 20240059775
    Abstract: The invention provides antibodies that specifically bind to PD-L1 and fusion molecules comprising PD-L1 binding proteins constructed with an IL 15 receptor-binding domain, nucleic acid molecules encoding the same, and therapeutic compositions thereof. The agents inhibit PD-L1-mediated immunosuppression and enhance cell and cytokine mediated immunity for the treatment of neoplastic and infectious diseases.
    Type: Application
    Filed: March 9, 2020
    Publication date: February 22, 2024
    Inventors: Samuel D. Waksal, Zhenping Zhu, Yan Wu, Stella A. Martomo, Zhaojing Zhong, Dan Lu
  • IMMUNOMODULATORY AGENTS
    Publication number: 20210022773
    Abstract: The invention provides antibodies that specifically bind to PD-L1 and fusion molecules comprising PD-L1 binding proteins constructed with an IL 15 receptor-binding domain, nucleic acid molecules encoding the same, and therapeutic compositions thereof. The agents inhibit PD-L1-mediated immunosuppression and enhance cell and cytokine mediated immunity for the treatment of neoplastic and infectious diseases.
    Type: Application
    Filed: March 9, 2020
    Publication date: January 28, 2021
    Inventors: Samuel D. Waksal, Zhenping Zhu, Yan Wu, Stella A. Martomo, Zhaojing Zhong, Dan Lu
  • Immunomodulatory agents
    Patent number: 10407502
    Abstract: The invention provides antibodies that specifically bind to PD-L1 and fusion molecules comprising PD-L1 binding proteins constructed with an IL15 receptor-binding domain, nucleic acid molecules encoding the same, and therapeutic compositions thereof. The agents inhibit PD-L1-mediated immunosuppression and enhance cell and cytokine mediated immunity for the treatment of neoplastic and infectious diseases.
    Type: Grant
    Filed: January 15, 2015
    Date of Patent: September 10, 2019
    Assignee: KADMON CORPORATION, LLC
    Inventors: Samuel D. Waksal, Zhenping Zhu, Yan Wu, Stella Martomo, Zhaojing Zhong, Dan Lu
  • IMMUNOMODULATORY AGENTS
    Publication number: 20160340429
    Abstract: The invention provides antibodies that specifically bind to PD-L1 and fusion molecules comprising PD-L1 binding proteins constructed with an IL15 receptor-binding domain, nucleic acid molecules encoding the same, and therapeutic compositions thereof. The agents inhibit PD-L1-mediated immunosuppression and enhance cell and cytokine mediated immunity for the treatment of neoplastic and infectious diseases.
    Type: Application
    Filed: January 15, 2015
    Publication date: November 24, 2016
    Inventors: Samuel WAKSAL, Zhenping ZHU, Yan WU, Stella MARTOMO, Zhaojing ZHONG, Dan LU